 Patients with impaired IL-17R signaling suffer from yeast infections, such as CMC (chronic mucocutaneous candidiasis), or respiratory infections.Apart from production of these inflammatory products "de novo", signaling via IL-17R also promotes stabilization of already existent specific mRNA transcripts.This stabilization prolongs the half-life of mRNAs and prevents their quick degradation.